文献速递肿瘤 PET/CT

晚期PSMA配体PET/CT在区分淋巴结转移与神经节中的作用

The role of additional late PSMA-ligand PET/CT in the differentiation between lymph node metastases and ganglia.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2019-12-21

PURPOSE: Differentiating between prostate cancer (PC) lesions and benign structures which exhibit radiotracer uptake in PSMA-ligand PET/CT can be challenging.…

要点

  • 晚期PSMA PET/CT中,73%淋巴结SUVmax升高,65%神经节SUVmax下降或稳定。
  • 仅凭晚期SUVmax升高不能可靠区分神经节与前列腺癌病灶,存在诊断陷阱。
  • 推荐结合高分辨率CT对神经节进行形态学表征以辅助鉴别。

核心结论

  • 晚期显像中潜在前列腺癌病灶的摄取增高可提供恶性可能性信息,但仅凭SUVmax升高不能可靠区分神经节与前列腺癌病灶,是潜在诊断陷阱。
  • 推荐使用高分辨率CT对神经节进行形态学表征以辅助鉴别。

研究设计与样本

  • 分析所有高于局部背景的神经节和前列腺癌病灶的SUVmax及定位。

主要发现

  • 70%(35例)患者中识别出86个PSMA阳性神经节,其中5个仅在晚期显像显示PSMA亲和性,3个仅在标准显像显示。
  • 44例(88%)患者中检测到66个提示前列腺癌的病灶,其中45%(30个)形态学确定为淋巴结,其余为局部复发或骨转移。
  • 晚期扫描中,73%的淋巴结SUVmax升高,而65%的神经节SUVmax下降或稳定。

临床怎么用

  • 在PSMA PET/CT中遇到潜在前列腺癌病灶时,应结合晚期显像SUVmax变化和高分辨率CT形态学特征鉴别神经节与转移。
  • 避免仅凭晚期SUVmax升高判断恶性,以防将神经节误诊为前列腺癌病灶。

局限性

  • 未包含实体器官转移灶,结论可能不适用于所有病灶类型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Differentiating between prostate cancer (PC) lesions and benign structures which exhibit radiotracer uptake in PSMA-ligand PET/CT can be challenging. Additional late imaging has been shown to be a powerful method for the discrimination between PC and non-PC lesions, owing to the increasing tracer uptake of the former. Nevertheless, there are no pre-existing studies which describe the dynamic tracer uptake for ganglia, which this present study aims to address. METHODS: Fifty consecutive patients with PC who received standard and late 68Ga-PSMA-11-PET/CT (by local protocol at 1.5 h "standard" and 2.5 h p.i. "late") underwent retrospective evaluation. All lesions with a tracer uptake above local background indicative for ganglia as well as PC lesions were analysed with regard to their maximum standardised uptake values (SUVmax) and localisation. RESULTS: Overall, 86 PSMA-positive ganglia were identified in 70% (n = 35) of the patients. Five ganglia exhibited PSMA avidity at late imaging only, and three at standard imaging only. A total of 66 lesions suggestive for PC were detected in 44 patients (88%), of which 45% (n = 30) were morphologically identified as lymph nodes (LN), the remainder being locally recurrent lesions or bone metastases. No solid organ metastases were present in our cohort. At late scanning, 73% of the LN exhibited an increase in SUVmax, whereas 65% of the ganglia exhibited a decreasing or stable SUVmax. CONCLUSION: Whereas the presence of increasing tracer uptake in potential PC lesions can provide additional data about the likelihood of malignancy, increasing SUVmax alone does not reliably differentiate between ganglia and PC lesions and is a potential diagnostic pitfall. We therefore recommend high-resolution CT to enable morphological characterisation of ganglia.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Alberts I, Sachpekidis C, Dijkstra L, et al. The role of additional late PSMA-ligand PET/CT in the differentiation between lymph node metastases and ganglia. Eur J Nucl Med Mol Imaging. 2019. PMID: 31865408. doi:10.1007/s00259-019-04552-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。